BICO Group AB (publ) (STO:BICO)

Market Cap	1.20B -61.1%
Revenue (ttm)	1.50B -23.1%
Net Income	-1.09B
EPS	-15.43
Shares Out	70.57M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	181,342
Average Volume	208,952
Open	17.20
Previous Close	17.04
Day's Range	16.80 - 17.23
52-Week Range	15.30 - 42.46
Beta	2.77
RSI	47.36
Earnings Date	Apr 29, 2026

About BICO Group AB

BICO Group AB (publ) provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally. It operates through three segments: Bioprinting, Life Science Solutions, and Lab Automation. The Bioprinting segment offers 3D bioprinters and bioinks with a range of technologies for various applications, resolutions, and volume/speed requirements, as well as provides services focused on accelerating drug discovery and development. The Life Science Solutions segment supplies lab instrumentation, consumables...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2016
• Employees: 567
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: BICO

Financial Performance

In 2025, BICO Group AB's revenue was 1.50 billion, a decrease of -23.07% compared to the previous year's 1.95 billion. Losses were -1.09 billion, 19698.2% more than in 2024.